Business Context and Reporting Period
Zura Bio Ltd (ZURA), an emerging growth company incorporated in the Cayman Islands, filed this Form 8-K on June 18, 2026, reporting events from its Annual General Meeting of Shareholders held on June 17, 2026.
Key Financial Metrics
This filing is a Current Report regarding corporate governance and shareholder voting outcomes. It does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data.
Material Changes and Voting Results
Shareholders approved four key proposals at the Annual Meeting:
- Election of Directors: All eight nominees were elected. Notably, Jennifer Jarrett and Amit Munshi received significant "Against" votes (16,471,044 and 16,027,697 respectively) compared to other nominees who received fewer than 500,000 "Against" votes.
- Auditor Ratification: Shareholders ratified the appointment of WithumSmith+Brown, PC as the independent registered public accounting firm for the fiscal year ending December 31, 2026.
- Equity Incentive Plan: Shareholders approved the amendment and restatement of the 2023 Equity Incentive Plan. This proposal received 38,850,373 votes "For" and 17,403,607 votes "Against."
- Adjournment: The proposal to adjourn the meeting to solicit additional proxies was not put to a vote as the other proposals were approved.
Guidance, Outlook, and Risks
The filing does not provide management commentary on financial guidance, future outlook, or specific risk factors. The primary focus is the successful execution of shareholder votes and the immediate effectiveness of the Amended 2023 Equity Incentive Plan.
Investor Verification Checklist
- Review the Definitive Proxy Statement (Schedule 14A) filed on April 30, 2026, for detailed terms of the Amended 2023 Equity Incentive Plan.
- Analyze the significant dissenting votes against directors Jennifer Jarrett and Amit Munshi to understand shareholder sentiment regarding board composition.
- Verify the specific terms of the Amended 2023 Plan in Exhibit 10.1 attached to this filing.
- Confirm the company's status as an emerging growth company and its election regarding extended transition periods for accounting standards.